136 related articles for article (PubMed ID: 2693257)
1. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
Kristen P; Beier HJ; Kaesemann H; Caffier H
Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
[No Abstract] [Full Text] [Related]
2. [CA546, CA602].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():647-50. PubMed ID: 16149602
[No Abstract] [Full Text] [Related]
3. Combination of markers may prove useful in screening for ovarian CA.
Oncology (Williston Park); 1994 Jun; 8(6):79-80. PubMed ID: 8074986
[No Abstract] [Full Text] [Related]
4. [Tumor marker CA 72-4 in ovarian cancer in comparison with CA 125 and D-dimer].
Schelling M; Jänicke F; Senekowitsch R; Lörken A
Gynakol Rundsch; 1991; 31 Suppl 2():286-9. PubMed ID: 1665138
[No Abstract] [Full Text] [Related]
5. [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
Sevelda P; Rosen A; Barrada M; Gober S; Vavra N; Salzer H
Gynakol Rundsch; 1990; 30 Suppl 1():210-1. PubMed ID: 2079273
[No Abstract] [Full Text] [Related]
6. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
7. Unique case of massive ascites, extreme elevation of serum CA 125 tumour marker.
Jotkowitz MW; Gee DC
Aust N Z J Obstet Gynaecol; 1993 Nov; 33(4):453-4. PubMed ID: 8179576
[No Abstract] [Full Text] [Related]
8. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
Nagele F; Vavra N; Kurz C; Sevelda P
Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
[TBL] [Abstract][Full Text] [Related]
9. [Experiences with the cancer marker CA 125 in gynecologic diseases].
Pilgrim G; von Broen B; Johannsmeyer KD
Z Gesamte Inn Med; 1989 Apr; 44(8):251-4. PubMed ID: 2741520
[TBL] [Abstract][Full Text] [Related]
10. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
[TBL] [Abstract][Full Text] [Related]
11. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
[No Abstract] [Full Text] [Related]
12. [Clinical management of cystic ovarian tumors].
Osmers R; Völksen M; Hinney B; Kühnle H; Rath W; Teichmann A; Wuttke W; Kuhn W
Geburtshilfe Frauenheilkd; 1990 Jan; 50(1):20-8. PubMed ID: 2138109
[TBL] [Abstract][Full Text] [Related]
13. [High CA-125 values in a patient with miliary tuberculosis and ascites].
Klein M; Marczewski A; Rosen A; Beck A
Gynakol Rundsch; 1989; 29 Suppl 2():355-6. PubMed ID: 2613049
[No Abstract] [Full Text] [Related]
14. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
15. Meigs syndrome with elevated serum CA 125.
Lin JY; Angel C; Sickel JZ
Obstet Gynecol; 1992 Sep; 80(3 Pt 2):563-6. PubMed ID: 1495739
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M
Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
[TBL] [Abstract][Full Text] [Related]
17. Monitoring CA 125 serum levels during early chemotherapy is an excellent prognostic method in advanced ovarian cancer.
Högberg T; Kågedal B
Gynecol Oncol; 1993 Mar; 48(3):413-4. PubMed ID: 8462909
[No Abstract] [Full Text] [Related]
18. [CA546, CA602].
Yamashita H; Kataoka F; Aoki DA
Nihon Rinsho; 2010 Jul; 68 Suppl 7():688-90. PubMed ID: 20960852
[No Abstract] [Full Text] [Related]
19. [CA546, CA602].
Nozawa S; Fukuchi T
Nihon Rinsho; 1999 Dec; 57 Suppl():470-3. PubMed ID: 10778167
[No Abstract] [Full Text] [Related]
20. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
